These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24971583)

  • 41. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
    Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA
    Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
    Reis B; Attig J; Dziadek S; Graefe N; Heller A; Rieder N; Gomes B
    Front Immunol; 2024; 15():1285049. PubMed ID: 38455061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probing the stability of class I major histocompatibility complex (MHC) molecules on the surface of human cells.
    Edidin M; Achilles S; Zeff R; Wei T
    Immunogenetics; 1997; 46(1):41-5. PubMed ID: 9148787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus.
    Harada N; Fukaya S; Wada H; Goto R; Osada T; Gomori A; Ikizawa K; Sakuragi M; Oda N
    J Immunol; 2017 Jan; 198(1):516-527. PubMed ID: 27881704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell surface expression of HLA-E: interaction with human beta2-microglobulin and allelic differences.
    Ulbrecht M; Couturier A; Martinozzi S; Pla M; Srivastava R; Peterson PA; Weiss EH
    Eur J Immunol; 1999 Feb; 29(2):537-47. PubMed ID: 10064069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A chimeric HLA-A2:β2M:Ig fusion protein for the study of virus-specific CD8
    Ribeiro ÁL; Araújo FP; Martins JP; Lourenço AA; Huang J; Pereira FV; Andrade LAF; Paim AAO; da Fonseca FG; Barbosa-Stancioli EF; Martins-Filho OA; Peruhype-Magalhães V; Tsuji M; Coelho-Dos-Reis JG
    J Immunol Methods; 2021 May; 492():112997. PubMed ID: 33600818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells.
    Benoit LA; Tan R
    J Immunol; 2007 Sep; 179(6):3588-95. PubMed ID: 17785793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
    Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
    Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
    Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
    Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
    Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
    J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen presentation genes in gadoid species (haddock: Melanogrammus aeglefinus and Atlantic cod: Gadus morhua) raise questions about cross-presentation pathways and glycosylated beta-2-microglobulin.
    Frenette A; Booman M; Fujiki K; Kales S; Ryan C; Gamperl AK; Dixon B
    Mol Immunol; 2021 Jan; 129():21-31. PubMed ID: 33260037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
    Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
    Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer.
    Chen HL; Gabrilovich D; Virmani A; Ratnani I; Girgis KR; Nadaf-Rahrov S; Fernandez-Viña M; Carbone DP
    Int J Cancer; 1996 Sep; 67(6):756-63. PubMed ID: 8824545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
    Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
    Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
    Desai SA; Wang X; Noronha EJ; Zhou Q; Rebmann V; Grosse-Wilde H; Moy FJ; Powers R; Ferrone S
    J Immunol; 2000 Sep; 165(6):3275-83. PubMed ID: 10975844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
    Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
    Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.